Sales rise for blood-screening system kits, company reports

03/1/2012 | CBS MoneyWatch

Cerus reported it saw an increase in revenue in the fourth quarter due in part to higher sales of disposable kits used with its Intercept blood-screening system, which eliminates bacteria, viruses and parasites in donated platelets. The company said it is preparing to initiate two late-stage clinical trials involving its screening system for red blood cells.

View Full Article in:

CBS MoneyWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA